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Prolonged fasting elicits increased 
hepatic triglyceride accumulation 
in rats born to dexamethasone-
treated mothers
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Junia Carolina Santos-Silva2, Daniella Esteves Duque-Guimaraes1, Frhancielly S. Sodré1, 
Camilo Lellis-Santos3, Juliana Camargo Vieira1, Dailson Nogueira de Souza2, Patrícia 
Rodrigues Gomes1, Sandra Campos Rodrigues1, Gabriel Forato Anhe2 & Silvana Bordin1
We investigated the effect of dexamethasone during the last week of pregnancy on glucose and 
lipid metabolism in male offspring. Twelve-week old offspring were evaluated after fasting for 12-
hours (physiological) and 60-hours (prolonged). Physiological fasting resulted in glucose intolerance, 
decreased glucose clearance after pyruvate load and increased PEPCK expression in rats born to 
dexamethasone-treated mothers (DEX). Prolonged fasting resulted in increased glucose tolerance 
and increased glucose clearance after pyruvate load in DEX. These modulations were accompanied 
by accumulation of hepatic triglycerides (TG). Sixty-hour fasted DEX also showed increased citrate 
synthase (CS) activity, ATP citrate lyase (ACLY) content, and pyruvate kinase 2 (pkm2), glucose 
transporter 1 (slc2a1) and lactate dehydrogenase-a (ldha) expressions. Hepatic AKT2 was increased in 
60-hour fasted DEX, in parallel with reduced miRNAs targeting the AKT2 gene. Altogether, we show 
that metabolic programming by prenatal dexamethasone is characterized by an unexpected hepatic 
TG accumulation during prolonged fasting. The underlying mechanism may depend on increased 
hepatic glycolytic flux due to increased pkm2 expression and consequent conversion of pyruvate to non-
esterified fatty acid synthesis due to increased CS activity and ACLY levels. Upregulation of AKT2 due to 
reduced miRNAs may serve as a permanent mechanism leading to increased pkm2 expression.
Since the proposal of the thrifty phenotype theory by Hales and Barker1, a growing body of evidence has corrob-
orated the hypothesis that intrauterine growth restriction (IUGR) is associated with an increased risk of type 2 
diabetes (T2D) later in life2. Observational studies indicated that IUGR could potentially increase the long-term 
risk for T2D by impairing insulin sensitivity and the first phase of insulin secretion3, 4. Thus, the causal relation-
ship between IUGR and programmed glucose intolerance has been extensively tested in several animal models. 
Rats born to mothers subjected to a 50% food restriction exhibit permanent disruption in pancreatic beta cell 
development and glucose intolerance later in life5, 6. In addition to the limited availability of nutrients to the 
conceptus, excessive corticosterone levels observed in food-restricted pregnant rats are believed to play a role in 
metabolic programming of the offspring7.
Experimental data that support the thrifty phenotype theory have also shown that rats born to mothers treated 
with dexamethasone (DEX) during the last week of pregnancy have impaired glucose tolerance later in life8, 9. This 
effect seems to be particularly relevant for the hepatic metabolic changes found in rats born to DEX-treated moth-
ers, as these animals have increased levels of phosphoenolpyruvate carboxykinase (PEPCK), a limiting enzyme 
of gluconeogenesis9.
The role of the liver in energy metabolism, however, is not only attributed to its gluconeogenic capacity but 
also to an integral participation in lipid metabolism. The hepatic triacylglycerol (TG) content results from pools 
1Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, 
Brazil. 2Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil. 
3Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of Sao Paulo, Diadema, 
Brazil. Correspondence and requests for materials should be addressed to S.B. (email: sbordin@icb.usp.br)
Received: 12 April 2017
Accepted: 11 August 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIEntIFIC REPORTS | 7: 10367  | DOI:10.1038/s41598-017-10642-1
delivered to liver by chylomicron remnants or by non-esterified fatty acid (NEFA) uptake and esterification. In 
addition, hepatic sources of TGs are also derived from de novo NEFA synthesis from glucose10.
Insulin is the key endocrine signal that makes these metabolic pathways work dynamically during the 
fed-to-fasting transition. High insulin levels during the absorptive period act in the liver by suppressing glucone-
ogenesis and stimulating de novo NEFA synthesis11. Conversely, fasting conditions warrant high rates of hepatic 
gluconeogenesis and adipose tissue TG hydrolysis. Moreover, NEFA taken up by the liver will be either oxidized 
or esterified to TG, which will be secreted as very low-density lipoprotein (VLDL)10.
Evidence have shown that rats born to DEX-treated mothers are prone to accumulate high levels of TGs when 
exposed to high-caloric, fat-enriched diets during adult life12, 13. It is still uncertain if metabolic programming by 
prenatal DEX exposure is also characterized by an impaired adaptation of hepatic metabolism to prolonged nutri-
ent deprivation. To address this issue, we evaluated the effects of long lasting fasting periods on multiple aspects 
of glucose and lipid metabolism in offspring born to DEX-treated mothers.
Results
Rats born to DEX-treated mothers exhibit glucose intolerance when subjected to overnight 
fasting. We initially assessed body weights at birth to verify that our experimental protocol replicated a well-
known result of excess glucocorticoid in offspring8. As expected, the body weight at birth was reduced in those 
born to DEX-treated mothers. Control rats weighted 7.1 ± 0.2 g (n = 20), and DEX-offspring weighed 4.4 ± 0.1 g 
(n = 11) at birth (38% lower than control [CTL]; P < 0.05).
The metabolic programming in rats born to DEX-treated mothers was initially assessed in adult rodents sub-
jected to a 12-hour fast. Changes in glycemia after a glucose load are depicted in Fig. 1A. Our data demonstrate 
that offspring born to DEX-treated mother exhibit glucose intolerance over the course of a glucose tolerance test 
(GTT), as shown by increased values of the area under the curve (AUC) obtained from the GTT (82% higher than 
those from CTL; P < 0.05).
Figure 1. Glucose metabolism in 12-hour fasted rats born to DEX-treated mothers. (A) GTT, (B) ITT and 
(C) PTT were performed in 12-hour fasted CTL (rats born to untreated mothers) and DEX (rats born to 
DEX-treated mothers) rats. The AUCs were calculated for glucose tests and PTTs. The KITT was calculated for 
ITTs. (D) Hepatic determination of pck1 and gcpc mRNA was normalized to rpl37a expression. (E) Hepatic 
determination of PEPCK and G6Pase was normalized to β actin. Data are shown as the mean ± S.E.M.; 
*p < 0.05 vs. CTL.
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Insulin tolerance tests (ITTs) were performed to assess putative changes in whole-body insulin sensitivity. The 
glucose decay after the load with exogenous insulin and the constant rate for glucose disappearance (KITT) were 
similar between CTL and rats born to DEX-treated mothers (Fig. 1B).
To evaluate if the impaired glucose tolerance of rats born to DEX-treated mothers was associated with 
increased whole-body gluconeogenesis, we performed the pyruvate tolerance test (PTT). The glucose levels 
after a pyruvate load are shown in Fig. 1C. Our data reveal that rats born to DEX-treated mothers exhibited a 
reduced clearance of glucose after a challenge with pyruvate, as shown by a greater AUC observed in rats born to 
DEX-treated mothers (54% higher than that of CTL animals; P < 0.05).
Reduced clearance of glucose after a pyruvate load in rats born to DEX-treated mothers matched with an 
increased pck1 expression in the liver (96% higher than CTL; P < 0.05). No differences were found in g6pc expres-
sion (Fig. 1D) or glucagon and insulin levels (not shown). Western blot analysis revealed that increased protein 
levels of PEPCK were present in the liver of rats born to DEX-treated mothers (80% higher than CTL; P < 0.05). 
Representative of g6pc gene expression, rats born to DEX-treated mothers showed unaltered levels of G6Pase 
protein (Fig. 1E).
Rats born to DEX-treated mothers have increased tolerance to exogenous glucose when sub-
jected to a prolonged fast. The initial analysis revealed that excess glucocorticoid during pregnancy 
resulted in glucose intolerance along with increased hepatic PEPCK expression and gluconeogenesis. To evaluate 
if these effects are sustained during a prolonged fast, we initially assessed fasting glycemia during progressive 
intervals of food deprivation. Surprisingly, we found that rats born to DEX-treated mothers exhibited lower glu-
cose levels with prolonged fasting. Rats born to DEX-treated mothers showed reduced glucose level after a 48-, 
60- and 72-hour fast (respectively, glucose levels were 13%, 18% and 13% lower than CTL; P < 0.05; Fig. 2A).
In an attempt to better characterize the metabolic response to a prolonged food deprivation period in rats 
born to DEX-treated mothers, we performed in vivo metabolic assays after a 60-hour fast. When subjected to 
a 60-hour fast, rats born to DEX-treated mothers presented lower glucose levels throughout the course of the 
GTT, which resulted in reduced AUCs (67% lower than CTL values; P < 0.05; Fig. 2B). Although rats born to 
DEX-treated mothers became more tolerant to glucose after the 60-hour fast, they exhibited discrete whole-body 
insulin resistance, as shown by reduced values of KITT (15% lower than CTL; P < 0.05; Fig. 2C).
In parallel to an increased tolerance to exogenous glucose, a 60-hour fast in rats born to DEX-treated mothers 
also resulted in lower glucose levels after a challenge with pyruvate. Thus, the AUCs obtained from the PTT in 
rats born to DEX-treated mothers were reduced when compared to those obtained from CTL rats (71% lower; 
P < 0.05; Fig. 2D). Livers obtained from 60-hour fasted rats born to DEX-treated mothers exhibited reduced lev-
els of pck1 (28% lower than CTL; P < 0.05) but unchanged levels of g6pc (Fig. 2E). This change in mRNA expres-
sion did not translate into changes in protein content because both PEPCK and G6Pase levels were unaltered in 
rats born to DEX-treated mothers (Fig. 2F).
Sixty-hour fasted CTL rats and 60-hour fasted rats born to DEX-treated mothers showed a similar increase in 
insulin levels in response to glucose. Both groups demonstrated a 90% increase in insulin levels at 15 min after the 
glucose injection. The values of circulating insulin remained similar between the two groups up to 30 min after 
the glucose load (Fig. 2G).
Rats born to DEX-treated mothers have increased hepatic TG accumulation when subjected to 
a 60-hour fast. To elucidate the fate of glucose and pyruvate after a prolonged period of food deprivation 
in rats born to DEX-treated mothers, we assessed circulating and hepatic parameters of lipid metabolism after 
subjecting the rats to a 60-hour fast. Circulating TGs, NEFA, cholesterol and lactate were similar between CTL 
rats and rats born to DEX-treated mothers (Fig. 3A). Hepatic levels of TGs, NEFA and cholesterol, however, were 
increased in rats born to DEX-treated mothers (59%, 110% and 32% higher than CTL, respectively; P < 0.05), 
and glycogen was reduced to 76% of CTL values (P < 0.05). The levels of hepatic lactate were similar between the 
two groups (Fig. 3B). Increased TG content in the liver of rats born to DEX-treated mothers was also detected 
by analysis of liver sections stained with Oil Red O (42% higher than CTL; P < 0.05; Fig. 3F). The activity of 
L-3-hydroxyacyl CoA dehydrogenase (β-HAD) was assessed as a representative step of fatty acid β-oxidation. 
Similar levels of β-HAD activity were found in the livers of CTL and rats born to DEX-treated mothers (Fig. 3C). 
Lactate dehydrogenase (LDH) and citrate synthase (CS) activities were increased in the liver of rats born to 
DEX-treated mothers (respectively, 30% and 41% higher than CTL; P < 0.05; Fig. 3D and E). The content of ATP 
citrate lyase (ACLY) was also increased in the liver of rats born to DEX-treated mothers (40% higher than CTL; 
P < 0.05; Fig. 3G).
To better understand the increased levels of TGs in the liver of 60-hour fasted rats born to DEX-treated moth-
ers, we analyzed the expression of several genes that encode proteins related to lipid metabolism. Two impor-
tant transcription factors that control the expression of several enzymes related to de novo fatty acid synthesis 
and esterification into TGs, srebf1 and Yin Yang 1 (YY1), were evaluated. Both srebf1 and YY1 expressions were 
increased in the liver of rats born to DEX-treated mothers (respectively, 45% and 75% higher than CTL; P < 0.05). 
Expression of the enzymes related to de novo fatty acid synthesis acetyl CoA carboxylase (acc), fatty acid synthase 
(fasn) and stearoyl-CoA desaturase (scd), the fatty acid transporter CD36 and diacylglycerol acyltransferase 2 
(dgat2) were similar between the groups. Similarly, we did not detect differences in the expression of proteins 
related to VLDL synthesis, assembly or secretion, such as apolipoprotein B (ApoB), microsomal transfer protein 
(MTTP) and SEC. 22b (Fig. 4A).
Hepatic secretion of VLDL-TG was also evaluated by assessing TG accumulation in blood after a challenge 
with tyloxapol, an inhibitor of lipoprotein lipase (LPL). Rats born to DEX-treated mothers showed a more pro-
nounced capacity to accumulate TGs in the blood than the CTL rats when subjected to a 60-hour fast, as shown 
www.nature.com/scientificreports/
4SCIEntIFIC REPORTS | 7: 10367  | DOI:10.1038/s41598-017-10642-1
by increased TG concentrations at 3 and 6 hours after tyloxapol injection in rats born to DEX-treated mothers 
compared to CTL rats (39% and 66% higher than CTL, respectively; P < 0.05; Fig. 4B).
Rats born to DEX-treated mothers have increased AKT2 levels and reduced putative miRNAs 
targeting AKT2 after a prolonged fast. We also evaluated the changes in insulin signaling that could 
have mediated the hepatic lipogenesis after a 60-hour fast. Rats born to DEX-treated mothers had increased fork-
head box protein O1 (FoxO1) phosphorylation compared to CTL rats (299% higher than CTL; P < 0.05; Fig. 5A). 
AKT2 and Raptor protein content was also increased in the liver of rats born to DEX-treated mothers (respec-
tively, 34% and 49% higher than CTL; P < 0.05; Fig. 5B and C). The expression of pyruvate kinase 2 (pkm2), 
known to be regulated by AKT2 and mammalian target of rapamycin (mTOR)14, 15, was also increased in the liver 
of 60-hour fasted rats born to DEX-treated mothers (54% higher than CTL; P < 0.05; Fig. 5D).
PKM2 modulates the expression of several genes, including slc2a1 and lactate dehydrogenase a (ldha)16. 
Favoring the proposition that PKM2 is likely to play a functional role in our model, 60-hour fasted rats born to 
Figure 2. Glucose metabolism in 60-hour fasted rats born to DEX-treated mothers. (A) Blood glucose levels 
were determined at different time points in CTL (rats born to untreated mothers) and DEX (rats born to DEX-
treated mothers) rats during a 72-hour fasting period. (B) GTT, (C) ITT and (D) PTT were performed in 60-
hour fasted CTL and DEX rats. The AUCs were calculated for glucose tests and PTTs. The KITT was calculated 
for ITTs. (E) Hepatic determination of pck1 and gcpc mRNA was normalized to rpl37a expression (F) Hepatic 
determination of PEPCK and G6Pase was normalized to β actin. (G) Circulating insulin was assessed at specific 
time points during the GTT. Data are shown as the mean ± S.E.M.; *p < 0.05 vs. CTL.
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DEX-treated mothers showed an increased expression of slc2a1 and ldha (respectively, 104% and 52% higher than 
CTL; P < 0.05). On the other hand, the expression of lactate dehydrogenase b (ldhb), a marker of oxidative phos-
phorylation, was reduced in 60-hour fasted rats born to DEX-treated mothers (36% lower than CTL; P < 0.05; 
Fig. 5E).
Next, we investigated whether programmed miRNAs were involved in the regulation of hepatic AKT2 expres-
sion due to early DEX exposure. Although hundreds of transcripts were predicted by the algorithms, only 18 
were commonly indicated by all databases (Fig. 5F). Among these, 9 displayed binding sites classified as highly 
conserved among species either by TargetScan or miRanda. We then analyzed the expression of the top 5 miRNAs 
with conserved sites in the Akt2 mRNA 3’ untranslated region (3′UTR), according to the scoring system calcu-
lated by TargetScan (Supplementary Table S1).
Expression of miR-34a-5p, miR-34c-5p, miR-124-3p, and miR-150-5p (respectively, 52%, 56%, 47% and 20% 
lower than CTL; P < 0.05) but not miR-449a was reduced in the liver of 60-hour fasted rats born to DEX-treated 
mothers (Fig. 5G).
Figure 3. Parameters related to glucose and lipid metabolism in 60-hour fasted rats born to DEX-treated 
mothers. (A) Serum levels of TGs, NEFA, cholesterol (Chol) and lactate were determined in CTL (rats born to 
untreated mothers) and DEX (rats born to DEX-treated mothers) rats subjected to a 60-hour fast. (B) One set 
of liver samples was used to measure glycogen, TGs, NEFA, Chol and lactate. (C, D and E) A second set of liver 
samples was processed for the determination of enzymatic activity of (C) β-HAD, (D) LDH and (E) CS. (F) TG 
content was also assessed by staining liver sections with Oil Red O. (G) Hepatic determination of ACLY was 
normalized to β actin. Data are shown as the mean ± S.E.M.; *p < 0.05 vs. CTL.
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Discussion
The present study presents evidence to show that metabolic programming induced by prenatal exposure to DEX 
is characterized by changes in glucose handling that depends on fasting duration. A physiological short-term 
fast elicits glucose intolerance hallmarked by increased pyruvate conversion into glucose and increased hepatic 
PEPCK in rats born to DEX-treated mothers. These changes are similar to previous findings9. In contrast, rats 
born to DEX-treated mothers exhibited increased tolerance to exogenous glucose compared to CTL rats after a 
prolonged period of food deprivation.
Interestingly, this adaptation was not accompanied by increased insulin sensitivity; instead, there was a dis-
crete insulin resistance. Thus, increased glucose uptake by insulin-sensitive tissues, such as skeletal muscle and 
white adipose tissue fat depots, are unlikely to account for the increased tolerance to exogenous glucose after a 
prolonged fast. We have also shown that the increase in insulin levels in 60-hour fasted rats born to DEX-treated 
mothers during the course of the GTT was similar to that of 60-hour fasted CTL rats. Thus, our data also rule out 
increased insulin secretion as the expected cause for increased glucose tolerance in 60-hour fasted rats born to 
DEX-treated mothers.
Metabolic programming induced by prenatal exposure to DEX is characterized by unaltered hepatic PEPCK 
content after a 60-hour fast. However, rats born to DEX-treated mothers, when fasted for 60 hours, showed a 
reduced conversion of exogenous pyruvate into glucose. Thus, the combined results of the GTT and the PTT sug-
gest that adult rats exposed to DEX during fetal life, under the condition of prolonged food deprivation, are likely 
to display increased hepatic consumption of glucose and glycolysis intermediates, such as pyruvate, to generate 
high amounts of Kreb cycle intermediates.
The increase in slc2a1 and pkm2 expression in the liver of 60-hour fasted rats born to DEX-treated mothers 
supports the notion of increased glycolysis rate. The increase in CS activity, in turn, supports the notion that the 
Figure 4. Expression of genes related to lipid metabolism and VLDL production in 60-hour fasted rats born to 
DEX-treated mothers. (A) Liver samples of CTL (rats born to untreated mothers) and DEX (rats born to DEX-
treated mothers) rats subjected to a 60-hour fast were processed for determination of cd36, acc, fasn, scd, dgat2, 
srebf1, YY1, mttp, apoB and sec. 22 mRNA. Data were normalized to rpl37a. (B) CTL and DEX rats fasted for 
60 hours were subjected to tyloxapol injection. The serum TG levels were measured at different time points after 
injection. Data are shown as the mean ± S.E.M.; *p < 0.05 vs. CTL.
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bulk of pyruvate (either exogenous or derived from glucose), rather than serving as a gluconeogenic substrate, is 
being converted into citrate in the liver of 60-hour fasted rats born to DEX-treated mothers.
Our data also support the proposition that citrate is probably being directed to de novo synthesis of NEFAs, 
given that 60-hour fasted rats born to DEX-treated mothers also had increased hepatic levels of ACLY, TGs and 
NEFAs.
Our study further suggests that increased hepatic de novo synthesis of NEFA is responsible for the hepatic 
TG accumulation in 60-hour fasted rats born to DEX-treated mothers. First, these rats showed no differences 
in hepatic expression of CD36, a transporter of circulating NEFA17. Second, circulating NEFA after a 60-hour 
fast was not altered by prenatal exposure to DEX. Thus, it is unlikely that increased hepatic NEFA uptake from 
the blood stream and its consecutive esterification would account for the differences in hepatic TG levels. 
Additionally, no evidence for a reduction in hepatic fatty acid β-oxidation has been found, as the rats born to 
DEX-treated mothers did not exhibit altered activity of hepatic β-hydroxyacyl-CoA dehydrogenase (β-HAD) 
after a 60-hour fast.
Our data have also shown that hepatic TG accumulation in the liver of rats born to DEX-treated mothers 
is equally unlikely to result from impaired VLDL production. This conclusion was drawn from the results of 
serum TG concentration after tyloxapol injection. Sixty-hour fasted rats born to DEX-treated mothers exhibited 
a more pronounced increased in serum TG concentration after tyloxapol injection when compared to 60-hour 
fasted CTL rats. Importantly, no changes were observed in the expression of mttp, apoB or sec. 22b, key players in 
hepatic VLDL production, assembly and secretion18, 19.
We believe that the higher levels of serum TG concentration found in rats born to DEX-treated mothers after 
tyloxapol injection are probably due to higher TG content in VLDL, rather than an increased in the number of 
VLDL particles. The increased TG content within VLDLs might be a direct consequence of increased hepatic 
TGs observed in these rats. In accordance with this hypothesis, it was already demonstrated that patients with 
nonalcoholic fatty liver disease (NAFLD) have increased serum concentration of TGs but not ApoB. Thus, the 
association between serum TGs and hepatic steatosis is suggested to be result of higher TG enrichment of VLDL 
particles20.
Additionally, increased serum TG concentration in 60-hour fasted rats born to DEX-treated mothers only 
becomes evident after an injection of tyloxapol, an LPL inhibitor. Thus, it is possible that, under prolonged fasting 
Figure 5. Signaling proteins and miRNAs in the liver of 60-hour fasted rats born to DEX-treated mothers. 
(A–C) One set of liver samples of CTL (rats born to untreated mothers) and DEX (rats born to DEX-treated 
mothers) rats subjected to a 60-hour fast was processed for western blot detection of (A) pFoxO1 normalized 
to FoxO1 and (B) AKT2 and (C) Raptor normalized to β-actin. (D and E) Liver samples of CTL and DEX 
rats fasted for 60 hours was processed for the determination of (D) pkm2 and (E) slc2a1, ldha and ldhb mRNA 
normalized to rpl37a expression. (F) In silico analysis using 3 available algorithms (TargetScan, miRanda 
and microT-CDS) was performed to identify miRNAs likely to physically bind to akt2 mRNA to control its 
expression. (G) Liver samples were also used for miR-34a-5p, miR-34c-5p, miR-124-3-3p, miR-150-5p and 
miR-449a determination, and the expression of each is normalized to RNU43 expression. Data are shown as the 
mean ± S.E.M.; *p < 0.05 vs. CTL.
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conditions, increased LPL-mediated TG depuration from VLDL in rats born to DEX-treated mothers yields 
unchanged serum TG levels. Another aspect that warrants consideration is that greater VLDL levels with a higher 
TG content were already described to have a lower half-life, being quickly removed from the blood stream21.
Experiments with liver-specific knockout mice have demonstrated that hepatic AKT2 is required for de novo 
lipogenesis and TG accumulation22. Downregulation of de novo lipogenesis in mice lacking hepatic AKT2 was 
shown to correlate with concomitant reduction in the expression of srebf1 (the gene that encodes SREBP-1c) 
and its target genes, such as fasn, scd and acc22. In fact, data collected show that SREBP-1c activation plays an 
important role in insulin-induced de novo lipogenesis through AKT223. Furthermore, mTORC1 was described 
to be a relevant step downstream of AKT that leads to SREBP1c activation and de novo lipogenesis24, 25. Although 
we have found that a 60-hour fast increased expression of srebf1, AKT2 and Raptor (a specific component of the 
mTORC1 complex;26) in the liver of rats born to DEX-treated mothers, we have found no concomitant increase 
in the expression of enzymes that mediate NEFA synthesis, such as acc, fasn and scd. Thus, it is quite possible that 
Srebp1 is not playing a role in increased hepatic TG accumulation in rats born to DEX-treated mothers. This is 
plausible because Srebp1 is described to require other co-activators, such as NF-Y/CBF, CREB/ATF and Sp1 to 
efficiently stimulate gene expression27, 28.
Therefore, we propose that increased lipogenesis observed in our model results from increased metabolic flux 
through glycolysis with compensatory mitochondrial citrate synthesis. Citrate, rather than entering the Kreb 
cycle, is preferentially serving as substrate for ACLY to promote fatty acid synthesis. This metabolic adaptation, 
widely described in cancer cells and known as the Warburg effect or aerobic glycolysis, is hallmarked by high 
glycolytic rates, even in the presence of oxygen29. Metabolic intermediates directed toward de novo lipogenesis are 
important to the Warburg effect that enables cancer cell growth30.
The cause of the Warburg effect can rely on both mitochondrial defects and enhanced glycolytic activity31. 
Notably, AKT2 was described as one mediator of the growth of liver cancer cells by stimulating the expression of 
PKM215. AKT2-mediated control of PKM2 is also relevant for liver fat accumulation32. PKM2 expression and the 
Warburg effect were also described to depend on the mTOR complex14. This regulation seems to be bidirectional, 
as PKM2 can also activate the mTOR complex 1 (mTORC1) in cancer cells33. Aside from the established role 
of PKM2 in catalyzing pyruvate synthesis, this protein also functions as a transcriptional co-activator34. Upon 
stimulation, PKM2 translocates into the nucleus and stimulates the expression of slc2a1 (GLUT1) and LDHA 
expression by a c-myc-dependent mechanism16.
Collectively, our data support the unprecedented notion that metabolic programming by prenatal DEX is 
hallmarked by a Warburg-like effect, which becomes apparent during a prolonged fast. The livers of rats born 
to DEX-treated mothers displayed increased AKT2 and Raptor protein expression and pkm2 gene expression. 
Genes downstream to PKM2, such as slc2a1 and LDHA, were also increased. Alternatively, reduced levels of 
LDHB further indicates lower rates of oxidative phosphorylation. Increased FoxO1 phosphorylation strengthens 
the hypothesis that a 60-hour fast increases AKT activity in the liver of rats born to DEX-treated mothers. The 
reduction in FoxO1 content is likely to result from its degradation. AKT-mediated FoxO1 phosphorylation medi-
ates its translocation from the nucleus to the cytoplasm, where FoxO1 undergoes ubiquitination and proteasome 
degradation35. A plausible explanation for the increase in Raptor expression relies on a putative inhibition of its 
proteasome-mediated degradation due to increased AKT2 levels. Accordingly, proteasome-mediated degradation 
of Raptor is induced by pharmacological AKT inhibition36.
With an attempt to understand the epigenetic basis of the programmed increased in AKT2 levels, we have 
searched for potential miRNAs that regulate AKT2 expression. In silico analysis scored nine miRNAs as com-
monly conserved putative regulators of the rat AKT2 gene. Four of these miRNAs were downregulated in the liver 
of rats born to DEX-treated mothers (miR-34a-5p, miR-34c-5p, miR-124-3-3p and miR-150-5p). Importantly, 
human AKT2 was previously described as a validated target for miR-124-3p37, and its binding sequence in both 
human and rat mRNAs is preserved and shares complete homology. Conservation is an important feature when 
predicting miRNA target sequences, as true binding sites are likely to be preserved under selective pressure38. 
Additionally, an increase in phosphorylated AKT after the inhibition of the miR-34 family has been observed39. 
Thus, our data indicate that AKT2 is likely to be regulated by miRNAs in the liver of rats born to DEX-treated 
mothers.
In summary, the present data describe an unknown feature of metabolic programming induced by prenatal 
DEX that is characterized by improper de novo lipogenesis of the liver during a prolonged fast. This metabolic 
adaptation leads to hepatic TG accumulation and is likely to result from increased glycolytic flux as a consequence 
of upregulated hepatic pkm2. Increased pkm2 expression is paralleled by increased protein expression of AKT2 
and Raptor. We also believe that differential miRNA expression serves as a putative mechanism underlying the 
increase in hepatic AKT2 content.
Methods
Experimental design and animal treatment. Nulliparous Wistar rats (8 weeks old) were treated with 
DEX (0.2 mg/kg/day) diluted in the drinking water from the 14th to the 19th day of pregnancy, as previously 
described (Gomes et al., 2014). The offspring were weaned on the 21st day of life and maintained on standard 
chow and water ad libitum. At 12 weeks old, the offspring were fasted for 12 h or 60 h prior to the experiments.
All studies were performed according to the guidelines of the Brazilian College for Animal Experimentation 
(COBEA) and were approved by the Ethics Committee on Animal Use at the Institute of Biomedical Sciences, 
University of Sao Paulo, Brazil.
Functional tests. Intraperitoneal glucose tolerance test (GTT). After fasting, rats were administered an i.p. 
glucose injection (2 g/kg of a 20% solution of D-glucose). Blood samples were collected from the tail at 0, 10, 15, 
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30, 60 and 120 min after the glucose injection for the measurement of blood glucose levels. The AUC of glycemia 
vs. time was calculated above each individual baseline (basal glycemia) to estimate glucose tolerance.
Intraperitoneal insulin tolerance test (ITT). After fasting, rats were administered an i.p. insulin injection (2 IU/
kg). Blood samples were collected from the tail at 0, 5, 10, 15, 20, 25 and 30 min after the insulin injection for 
the measurement of serum glucose levels. The KITT was calculated using the equation: 0.693/half-life. Glucose 
half-life was calculated from the slope of the least-squares analysis of the blood glucose concentrations during the 
linear phase of decay.
Intraperitoneal pyruvate tolerance test (PTT). Fasted rats were administered an i.p. injection containing sodium 
pyruvate solution (250 mg/ml) at a dosage of 2 g/kg. Glucose levels were determined in blood collected from the 
tail before (0 min) and 15, 30, 60, 90, and 120 min after the pyruvate injection. The AUC of glycemia vs. time was 
calculated using each individual baseline (basal glycemia) to estimate glucose production after a pyruvate load.
VLDL production assay. The LPL inhibitor tyloxapol (Triton WR-1339; Sigma Aldrich, St Louis, USA) was 
dissolved in isotonic saline 0.9% (V/V) with slight agitation. After a 60-h fast, rats were weighed and received an 
i.p. bolus injection of tyloxapol (500 mg/kg). Blood samples were collected form the tip of the tail at 1, 2, 3 and 
6 hours after tyloxapol injection, and triglyceride was measured immediately using a diagnosis kit (Labtest, Santa 
Lagoa, Brazil).
Blood sample analysis. Glucose, TGs, cholesterol, and NEFA levels were analyzed using standard commercial 
kits (Labtest Diagnóstica SA, MG, Brazil, for TGs and Cholesterol; HR Series NEFA-HR from Wako Chemicals, 
Richmond, VA, USA, for NEFA determination). Serum insulin concentration was determined by ELISA, accord-
ing to the manufacturer’s instructions (#EZRMI-13K, Millipore; MA, USA).
Tissue sample analysis. Liver samples were quickly removed, washed with ice-cold phosphate-buffered saline 
(PBS), frozen with liquid nitrogen and ground in a mortar. Powdered samples were maintained at −80 °C until 
used.
Glycogen content was strictly measured as previously described40. Lipid extraction from liver and skeletal 
muscle (soleus) samples was performed based on a method previously described41. Briefly, powdered tissue sam-
ples were homogenized in a 4-mL solution of CHCl3 and methanol (2:1, v/v) using a rotor-stator homogenizer. 
The homogenates were incubated for at least 16 h at 4 °C under gentle homogenization in a closed glass tube. After 
this, a 0.6% NaCl solution was added to the extracts and the mixtures were centrifuged at 2000 × g for 20 min. The 
organic layer was then collected and dried using an Eppendorf Vacuum Concentrator Plus (Eppendorf, Hamburg, 
Germany). The lipids were solubilized in 200 µL of isopropanol and quantified using standard commercial kits.
The activities of LDH (EC 1.1.1.27) and β-HAD (EC 1.1.1.35) were measured using spectrophotometric 
assays, following standard methods described elsewhere42, 43. CS (EC 4.1.3.7) activity was assayed using colorim-
etry at 412 nm, as previously described44.
Protein extraction and immunoblotting. Fragments of liver (approximately 100 mg) were removed and 
processed for western blotting, as previously described40. The primary antibodies used were as follows: anti-AKT2 
(cat. # 2962), anti-ACLY (cat. #4332) and anti-Raptor (cat. #22805) from Cell Signaling Technology (Danvers, 
MA, USA); anti-glucose-6-phosphatase (sc-27198) and anti-PEPCK (sc32879) from Santa Cruz Biotechnologies 
(Santa Cruz, CA, USA); anti-FOXO1A (ab52857) and anti-FOXO1A (phospho S256) (ab131339) from Abcam 
(Cambridge, UK). Anti-beta actin, (cat. # A3854; Sigma Aldrich, St Louis, USA), was used as the loading control. 
Secondary antibodies conjugated to horseradish peroxidase (Bio-Rad Laboratories, Hercules, CA) were used, 
followed by chemiluminescent detection of the bands on x-ray-sensitive films. Optical densitometry of the films 
was performed using the Scion Image analysis software (Scion Corp., Frederick, MD, USA). All images of the 
western blots are shown in Supplementary Figure S1.
Total RNA was extracted from approximately 100 mg of tissue using Qiazol reagent, and total RNA was used 
for both the reverse transcription with random primers for the analysis of mRNA expression and the poly(A) 
tailing for the analysis of miRNA expression45.
Primer sequences used for mRNA analysis are listed in Supplementary Table S2. Values of miRNA and mRNA 
expression were normalized using the geometric mean calculated from the internal control gene rpl37a or 
RNU43. Fold changes were calculated using the 2-ΔΔCT method.
Neutral lipids staining by Oil Red O. Liver sections were processed and analyzed as previously described46. 
Briefly, liver fragments were frozen in n-hexane with liquid nitrogen, and cryostat sections (12 μm) were mounted 
onto aminopropyltriethoxysilane-coated glass slides. From each block, exhaustive 12-μm serial sections were 
obtained (with 200 μm between sections) and randomly selected for analysis, and at least 3 sections were ana-
lyzed. Glass slides with the sections were incubated with Oil Red O for 5 min at room temperature and then rinsed 
with water. After rinsing, glass slides were coated with water-soluble mounting medium and coverslips. Images 
(four different fields of each section) were captured using a bright field Nikon Eclipse E800 microscope (Nikon, 
Tokyo, Japan) equipped with a digital camera (Nikon FDX-35, Nikon, Tokyo, Japan). Analysis was performed 
using the free software Image J (http://imagej.nih.gov/ij). Colored images were converted to grayscale and densi-
tometry was performed on the entire captured field. The section staining and image acquisition were performed 
in a single experimental round and analysis was performed assuming a constant background signal for all images. 
Data are presented as Oil Red O optical density.
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Prediction analysis of microRNAs that target AKT2. To identify miRNAs likely to physically bind to akt2 mRNA, 
which would control akt2 expression, we used 3 available algorithms (TargetScan, miRanda and microT-CDS) 
designed for predicting putative target sequences in the 3′UTR of metazoan mRNA.
Statistical analysis. All results are presented as the mean ± S.E.M. Comparisons were performed using 
an unpaired Student’s t-test or a one-way ANOVA followed by a Tukey-Kramer post hoc test, when appropriate 
(GraphPad Prism - Graph Pad Software, Inc., San Diego, USA). P values < 0.05 indicate a significant difference.
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